Shenzhen Lifotronic Technology Co., Ltd. (SHA:688389)

China · Delayed Price · Currency is CNY

13.07

-0.17 (-1.28%)

Mar 9, 2026, 3:00 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Unallocated Other Business	-	-						1.83M	1.76M
Unallocated Other Business Growth	-	-						3.61%	-
Treatment and Rehabilitation - Medical Products	197.57M	-						99.57M	61.78M
Treatment and Rehabilitation - Medical Products Growth	-	-						61.18%	-
Treatment and Rehabilitation - Home Products	22.46M	-						3.37M	2.41M
Treatment and Rehabilitation - Home Products Growth	-	-						39.89%	-
in Vitro Diagnostics - Inspection Equipment	259.63M	-						69.66M	61.04M
in Vitro Diagnostics - Inspection Equipment Growth	-	-						14.11%	-
in Vitro Diagnostics - Test Reagents	651.83M	-						76.41M	47.55M
in Vitro Diagnostics - Test Reagents Growth	-	-						60.70%	-
Total	1.13B	-						250.83M	174.54M
Total Growth	-	-						43.71%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	759.20M	-						233.71M	163.05M
China Growth	-	-						43.34%	-
Foreign	372.29M	-						15.29M	9.73M
Foreign Growth	-	-						57.24%	-
Total	1.13B	-						249.00M	172.77M
Total Growth	-	-						44.12%	-

Source: S&P Global Market Intelligence.